Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
This clinical trial update reports the termination of a Phase 2 open-label long-term extension study of bapineuzumab in patients with mild t…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) [Phase 3]
Phase 3 trial update for bapineuzumab in mild-to-moderate Alzheimer's disease, focusing on ApoE4 non-carriers. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) [Phase 3]
This entry reports the completion of a Phase 3 trial of bapineuzumab in mild-to-moderate Alzheimer's disease (ApoE4 carriers).
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD)) [NA]
An update on the Construction-LBD clinical trial for constructional apraxia in Alzheimer's disease and dementia with Lewy bodies, sponsored …
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients [Phase 4]
This Phase 4 trial update reports termination of a study examining whether regional brain volume predicts response to donepezil in Alzheimer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Study Evaluating Bapineuzumab In Alzheimer Disease Subjects [Phase 2]
Pfizer completed a Phase 2 study evaluating bapineuzumab in Alzheimer's disease. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: A Comparison of Two Standard Therapies in the Management of Dementia With Agitation [Phase 4]
Phase 4 clinical trial comparing two standard therapies for agitation in dementia has completed; the provided document does not include tria…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia [Phase 3]
Phase 3 trial of intramuscular aripiprazole for acute agitation in dementia patients (including Alzheimer's disease) has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions [Phase 1]
Phase 1 trial evaluating the PET tracer [18F] PBR111 as a marker of brain inflammation in Alzheimer's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial of aripiprazole for psychosis in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type [Phase 3]
A Phase 3 study evaluating aripiprazole for psychosis in patients with Alzheimer's-type dementia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC [EARLY_Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating the PET radiotracer [18F] FMH3 to assess histamine-3 recepto…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A
A follow-up study evaluating the long-term safety and tolerability of the AD03 immunization used during AFF005A for Alzheimer's disease has …
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating T-817MA for mild to moderate Alzheimer's disease has completed, reporting efficacy and safety findings.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type [Phase 2]
This update reports results from a Phase 2 trial evaluating three doses of NS 2330 in patients with mild to moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) [Phase 2, Phase 3]
This is a Phase II/III trial update of Florbetapir (18F) PET imaging conducted in Japan across healthy volunteers, mild cognitive impairment…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Study of Florbetapir (18F) in Japanese Healthy Volunteers [Phase 1]
Phase 1 study evaluating florbetapir F-18 in Japanese healthy volunteers; results were posted after completion in 2013.
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults [NA]
A Cleveland Clinic-sponsored clinical trial evaluating the impact of exercise and cognitive training on cognitive function in older adults h…
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease [NA]
A terminated Pfizer-sponsored trial evaluated the acute effects of donepezil on brain perfusion and memory in people with cognitive impairme…
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Zydena on Cognitive Function of Alzheimer's Disease Patients [Phase 3]
A Phase 3 clinical trial evaluating Zydena for cognitive function in Alzheimer's disease is in progress. The current status of the trial is …
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease [Phase 1]
A Phase 1 multiple ascending dose study of TC-5619 in healthy elderly subjects and individuals with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease [Phase 3]
A Phase 3 trial of galantamine for mild to moderate Alzheimer's disease was terminated, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of the investigational agent E2609 in healthy subjects…
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease [Phase 4]
A Phase 4 trial evaluating the efficacy of a combination regimen in patients with mild to moderate probable Alzheimer's disease has been com…
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease
A completed study investigating whether changes in attention with galantamine treatment correlate with changes in caregiver burden in Alzhei…